BJP RCPsych Publications
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Browne, B.
Right arrow Articles by Linter, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Browne, B.
Right arrow Articles by Linter, S.

The British Journal of Psychiatry 151: 210-212 (1987)
© 1987 The Royal College of Psychiatrists

Monoamine oxidase inhibitors and narcotic analgesics. A critical review of the implications for treatment

B Browne and S Linter
Newcastle General Hospital.

There has been a recent renewal of interest in the use of monoamine oxidase inhibitors, but the concurrent administration of narcotic analgesics is often a cause for concern. This review clarifies the different types of MAOI/narcotic interactions and offers guidelines for the use of narcotic analgesics in the presence of MAOIs. The MAOI/pethidine interaction has two distinct forms: an excitatory and a depressive form. Pethidine must never be used in the presence of MAOIs because of the risk of a fatal excitatory interaction. Morphine does not cause this excitatory interaction, and is the drug of choice provided an allowance is made for possible potentiation of the depressive narcotic effect. It is inevitable that strong analgesia will occasionally be required as an emergency measure in patients on MAOIs, and insufficient attention is paid in psychiatric textbooks to the two different types of interactions and their therapeutic implications.


This article has been cited by other articles:


Home page
 Journal of the American Dental AssociationHome page
M. SPINK, S. BAHN, and R. GLICKMAN
Clinical implications of cyclo-oxygenase-2 inhibitors for acute dental pain management: Benefits and risks
J Am Dent Assoc, October 1, 2005; 136(10): 1439 - 1448.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
S. A. Bernard and E. Bruera
Drug Interactions in Palliative Care
J. Clin. Oncol., April 1, 2000; 18(8): 1780 - 1799.
[Abstract] [Full Text] [PDF]

Home page
 J Intensive Care MedHome page
R. B. Shochet and G. B. Murray
Analytic Reviews : Neuropsychiatric Toxicity of Meperidine
J Intensive Care Med, September 1, 1988; 3(5): 246 - 252.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1987 The Royal College of Psychiatrists.